Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55721392)
Find a Category (125)
Find a Journal (6164)
Find a Scholar (4284)
Find an Academic Assistant (18)
Find an Article PDF (4641775)
Today's Articles (2836)
Subscriber (50449)
Citation(s) in
RCA
51
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2024 (1)
2023 (1)
2021 (2)
2020 (1)
2019 (1)
2017 (2)
2016 (1)
2013 (7)
2012 (3)
2011 (2)
Show more
Refine
Article Statistics
RCA (46)
SCIE (44)
PubMed (43)
Open (17)
ESCI (3)
Refine
Publication Titles
JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (4)
CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (3)
ACTA ACUSTICA UNITED WITH ACUSTICA (2)
ANNALS OF ONCOLOGY (2)
CANCER (2)
CLINICAL LUNG CANCER (2)
JOURNAL OF THORACIC ONCOLOGY (2)
LUNG CANCER (2)
THE NEW ENGLAND JOURNAL OF MEDICINE (2)
ADVANCED NANOBIOMED RESEARCH (1)
Show more
Refine
Category
Oncology (31)
Respiratory System (5)
Health Care Sciences & Services (4)
Medicine, General & Internal (3)
Medicine, Research & Experimental (3)
Multidisciplinary Sciences (3)
Public, Environmental & Occupational Health (3)
Biochemistry & Molecular Biology (2)
Pharmacology & Pharmacy (2)
Radiology, Nuclear Medicine & Medical Imaging (2)
Show more
Refine
For:
Shanafelt TD
, Loprinzi C, Marks R, Novotny P, Sloan J.
Are Chemotherapy Response Rates Related to Treatment-Induced Survival Prolongations in Patients With Advanced Cancer?
J Clin Oncol
2004;
22
:1966-74. [PMID:
15111619
DOI:
10.1200/jco.2004.08.176
]
[
Citation(s) in
RCA
: 51
]
[
Impact Index Per Article: 2.6
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/20/2022]
Open
Number
Cited by Other Article(s)
51
Markman M
. Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trial.
Curr Oncol Rep
2004;
6
:421-2. [PMID:
15485610
DOI:
10.1007/s11912-004-0070-x
]
[
Citation(s) in
RCA
: 2
]
[
Impact Index Per Article: 0.1
]
[
Reference Citation Analysis
]
[
MESH Headings
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Indexed: 11/30/2022]
Abstract
Collapse
Key Words
Collapse
MESH Headings
Antineoplastic Agents/therapeutic use
Biomedical Research/standards
Clinical Trials, Phase III as Topic/methods
Humans
Medical Oncology/methods
Randomized Controlled Trials as Topic/methods
Time Factors
Collapse
Grants
Collapse
Affiliation(s)
Collapse
Page 2 of 2
1
2
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…